Derm Cases · Medicine
OSCE — Spitz naevus (spindle and epithelioid cell naevus)
Eight-minute OSCE station on Spitz naevus (spindle and epithelioid cell naevus): focused history, examination priorities, investigations, emergency and definitive management.
On this page
Study tools
Target exams
Brief (to candidate)
You will assess a patient with a presentation consistent with Spitz naevus (spindle and epithelioid cell naevus).
You have 8 minutes to take a focused history, outline examination, investigations, and management including red flags.
Clinical context
Spitz naevus is a benign acquired melanocytic naevus of childhood and adolescence composed of large spindled and epithelioid melanocytes, presenting most often as a rapidly growing pink, hairless, dome-shaped papule. Histology shows spindled/epithelioid melanocytes, Kamino bodies, symmetry, and maturation with depth. The central diagnostic challenge is distinguishing benign Spitz naevus from spitzoid melanoma, with the atypical Spitz tumour occupying a borderline zone. Management is complete surgical excision with clear margins.
[3]Candidate tasks
- Clarify onset, severity, associated features, and red-flag symptoms.
- State focused examination priorities.
- List first-line investigations and any named score/criteria.
- Give immediate resuscitation steps.
- Outline definitive management with doses/routes where standard.
- Name complications and disposition (ward / HDU / theatre / discharge safety-net).
- Mention one special-population modifier (pregnancy, child, elderly, CKD).
Examiner checklist
| Domain | Pass behaviours |
|---|---|
| Definition | Correct working diagnosis language |
| Assessment | Focused, prioritised, red flags sought |
| Investigations | Appropriate first-line + interpretation |
| Emergency care | ABC / time-critical actions first |
| Definitive care | Specific drugs/procedures, not generic phrases |
| Safety | Spitz naevus |
| Safety | Spindle and epithelioid cell naevus |
| Safety | Benign juvenile melanoma (historical, misleading term) |
| Communication | Clear plan and safety-netting |
Model outline
Lead with the working diagnosis and life threats. Resuscitate before definitive tests when unstable. Use guideline-standard therapy with named agents and doses. Document escalation criteria and follow-up. A safe candidate is specific, structured, and never delays critical care for non-urgent imaging.[1]
References3ShowHide
- [1]LeBoit PE Spitz melanoma Clin Dermatol, 2025.PMID 39265841
- [2]Bartenstein DW, et al. Clinical features and outcomes of spitzoid proliferations in children and adolescents Br J Dermatol, 2019.PMID 30467833
- [3]Yeh I, Busam KJ Spitz melanocytic tumours - a review Histopathology, 2022.PMID 34958498